PanGenomic Health, Inc. Class A (TSE:NARA) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PanGenomic Health, Inc. has updated stakeholders on the status of their management cease trade order (MCTO), which was issued due to a delay in filing their annual financial documents for the year ended December 31, 2023. The company has settled its outstanding invoices with auditors and anticipates filing the necessary documents by June 28, 2024. Trading restrictions are currently in place for the CEO and CFO, but not for shareholders, and the company will continue to provide bi-weekly status reports until the MCTO is lifted.
For further insights into TSE:NARA stock, check out TipRanks’ Stock Analysis page.